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The present report discusses targeted and non-targeted approaches to monitor single nutrients
and global metabolite profiles in nutritional research. Non-targeted approaches such as meta-
bolomics allow for the global description of metabolites in a biological sample and combine
an analytical platform with multivariate data analysis to visualise patterns between sample
groups. In nutritional research metabolomics has generated much interest as it has the potential
to identify changes to metabolic pathways induced by diet or single nutrients, to explore
relationships between diet and disease and to discover biomarkers of diet and disease. Although
still in its infancy, a number of studies applying this technology have been performed; for
example, the first study in 2003 investigated isoflavone metabolism in females, while the most
recent study has demonstrated changes to various metabolic pathways during a glucose toler-
ance test. As a relatively new technology metabolomics is faced with a number of limitations
and challenges including the standardisation of study design and methodology and the need for
careful consideration of data analysis, interpretation and identification. Targeted approaches are
used to monitor single or multiple nutrient and/or metabolite status to obtain information on
concentration, absorption, distribution, metabolism and elimination. Such applications are
currently widespread in nutritional research and one example, using stable isotopes to monitor
nutrient status, is discussed in more detail. These applications represent innovative approaches
in nutritional research to investigate the role of both single nutrients and diet in health and
disease.
Metabolomics: Metabolite profiling: Stable isotopes: Nutrient physiology: Diet
Nutritional change is accepted as a cornerstone of public
health strategy in reducing the risk of many of the chronic
diseases that face Western society such as obesity, heart
disease and cancer. Nutritional status modulates virtually
all body processes, including various ongoing metabolic
processes(1). Currently, however, there is little under-
standing of the individual response to nutritional interven-
tion and the contribution that specific metabolites and
metabolic pathways make in physiological processes related
to health and disease(2). In trying to elucidate the aetiology
of multifactorial disease it is well accepted that genetic,
environmental and lifestyle factors are important mod-
ulators. Nutrition also plays an important role as it supplies
the metabolome (all metabolites within a biological
sample). During disease development early events lead to a
change to nutrient physiology and/or changes to metabolic
pathways, which will influence the whole metabolome and
may eventually lead to a metabolic disturbance and the
origins of a disease phenotype. Using traditional bio-
markers and conventional research tools it is not possible
to identify changes to nutrients and the metabolome at
these early stages when nutritional intervention could
potentially reduce disease risk back to a healthy phenotype.
However, there are now a number of approaches available
to monitor both single-nutrient physiology and global
metabolite profiles, and these approaches have shown
considerable potential in the study of how diet and the
metabolome interact. Such approaches can be defined
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as either targeted or non-targeted depending on the overall
experimental design. Targeted approaches are usually
hypothesis testing, as it presumes the target of the investi-
gation is known (nutrient or metabolite) and the aim of the
study is to measure its status. A non-targeted approach is
usually hypothesis generating, as typically it is designed to
provide a more global description of all metabolites pre-
sent in a biological fluid; thus, the target is actually the
whole metabolome and not a specific species. The aim then
is to identify species of interest that can be targeted for
further investigation and as such both approaches are
linked and complementary to each other.
Non-targeted approaches: metabolomics
Metabolomics is a relatively novel technology in nutri-
tional research and offers considerable potential as a result
of the wealth of information that potentially can be
obtained. There is increasing interest in the use of meta-
bolomics as a tool in understanding the effects of nutri-
tional intervention on the individual(1,3–10). A major
challenge is to understand the relationship between
nutrition and chronic disease, and a metabolomics-based
approach could be used analytically to predict sus-
ceptibility to metabolic diseases and elucidate molecular
mechanisms that can explain the beneficial effects of diet-
ary interventions. Furthermore, metabolomics is thought to
be a promising tool for biomarker discovery(2), with the
potential capacity to identify biomarkers of early-stage
disease and biomarkers of dietary patterns or individual
nutrients. Metabolomics is also seen as providing critical
information in the quest to transform current population-
based dietary guidelines into future personalised dietary
recommendations to help individuals maintain a healthier
status and prevent chronic diseases(11).
The technology can be summarised as a global analysis
or characterisation of all metabolites measured in a biolo-
gical sample (metabolome). The metabolome is a complex
mixture of thousands of compounds that arise from intra-
and extracellular metabolic pathways and external sources
such as food. As a result of the complexity of biological
fluids, with the large number of metabolites present, data
from biological mixtures are highly complex and generally
are processed using multivariate statistical analysis includ-
ing pattern recognition. These chemometric measurements
generate metabolic profiles or patterns of metabolites from
which it is then possible to detect changes to the normal
phenotype induced by, for example in relation to nutri-
tional studies, diet and metabolic disease. Although this
technology has been successfully used in nutritional studies,
there are still a number of considerations for its use.
Methodological considerations for
metabolomic investigations
Metabolomics requires an analytical platform to supply the
metabolite profiles before subsequent data processing.
A number of technology platforms are available to analyse
biological samples but NMR and MS are the commonest
and each has its own advantages and disadvantages.
Historically, NMR has been the platform of choice and still
represents the most common method for sample analysis in
metabolomics. More recently, MS technology has become
popular, with both liquid chromatography (LC) and GC
being successfully used. NMR requires no sample pre-
treatment and so the spectrum contains information on
both small-molecular-weight compounds and proteins;
however, sensitivity is relatively low. MS is highly sensi-
tive; however, it requires sample pretreatment in the
removal of proteins and hydrophobic compounds, thus
limiting potential information. Furthermore, the method of
protein precipitation or sample treatment also has its own
analytical considerations and influences the metabolite
profiles obtained. As pretreatment and a separation step are
needed, MS is not as reproducible as NMR. A general
consideration for metabolomic investigations is that no
single platform will provide information on all metabolites
present and a combination of NMR, LC–MS and GC–MS
would be required.
Experimental and analytical variation
Analytical design and variation in relation to metabolomics
has been extensively investigated(12–20). As each platform
has its own analytical requirements, variation arises from
the methodology used in the study and from the instrument
itself. Sample collection provides its own issues. Although
blood concentrations of metabolites are generally under
some sort of metabolic regulation, they are dynamic and
responsive to acute changes to the diet. Metabolite profiles
have been shown to be influenced by the blood collection
tubes(21), clotting times and clotting procedure(15). Urine
represents an ‘end point’ of metabolism, and as such is not
under any metabolic regulatory control as with plasma or
serum, and is often the sample of choice in metabolomics
investigations (it also requires limited pretreatment com-
pared with blood). However, urinary metabolite profiles
are heavily influenced by diurnal variation(12) and the use
of sample preservatives(22), especially if 24 h aliquots are
being obtained. The extent to which spot urines or first or
second void urines are representative has not yet been
established. The use of faeces (either lyophilised or faecal
water) is relatively new but can be useful for gut micro-
flora investigations. Sample storage is important; no dif-
ferences have been found in urinary or plasma metabolite
profiles when samples are stored for 0 or 24 h at 4C(23),
but for longer storage times sub-zero conditions (<- 20C)
should be used(14,22). Freeze–thaw cycles have not been
shown to influence metabolite profiles using LC–MS(14).
While NMR requires no sample pretreatment, MS
requires removal of proteins and hydrophobic lipids. Var-
ious methods for protein precipitation have been compared
in terms of the number of features obtained(13,24,25), with
similar observations finding methanol treatment to be the
most optimal for plasma samples; however, the variation in
profiles obtained from each pretreatment method is exten-
sive. Attempts have been made to further develop and
optimise the methodology for LC–MS-based metabolomic
studies(13,16,17,20,26). It is clear that the analytical conditions
associated with MS need to be further optimised and
standardised as sample pretreatment, run time, type of
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column, temperature and LC gradient all influence the
profiles obtained(13,16,17,20,26).
Biological variation
There is a complex relationship between genotype, meta-
bolic phenotype, diet, lifestyle and environment and the
nutritional needs of an individual(11). Human tissues and
cells respond to the delivery of nutrients by adapting their
metabolic processes through the regulation of gene tran-
scription, protein levels and enzyme activity. The end point
of these processes is that the levels of metabolites change;
however, as a result of large inter-individual variations in
genotype and phenotype human subjects differ widely
in their response to nutrients and diet overall(11) and thus
there is large inter-individual variability in metabolite
profiles.
The influence of biological variation has been the sub-
ject of some study(18,19,27,28). Considerable biological vari-
ation in metabolite profiles exists as a result of gender, age
and BMI(27,28) and it has been possible to classify samples
based on these characteristics. Increased plasma choline,
LDL, HDL and unsaturated fatty acids have been found in
women and increased VLDL, creatine and isoleucine in men
as discriminators of gender(27). Comparing age-groups, in
women plasma valine, isoleucine, alanine and tyrosine are
higher in the older population (>46 years v. 18–29 years)
while in men plasma lipoproteins and unsaturated lipids are
higher in the older population(27). Discriminators based on
BMI include choline and citrate, which are higher in a lean
population (BMI<21 kg/m2), while tyrosine, isoleucine and
glycoproteins are higher in an obese population (BMI>25
kg/m2)(27). Thus, in terms of study design there needs to be
a careful consideration of the population used, with limited
ranges of age and BMI and also taking into account blood
pressure(29), standard clinical chemistry and prescreening
questionnaires(10).
Dietary habits heavily influence metabolite profiles, as
foods contain thousands of compounds that supply the
metabolome. Populations can be classified according
to various dietary factors(29–31) and certain metabolites
have been shown to be related to specific dietary pat-
terns(30,32,33). For example, trimethylamine N-oxide is
related to acute intake of fish(30,31) while taurine and
creatine are increased during high meat intakes(30,32).
Careful dietary standardisation is therefore required before
sample collection(10,34), and indeed this approach has been
shown to decrease inter-individual variation in urinary
metabolite profiles(34).
There is a complex interaction between gut microflora
and host metabolism(35,36). As diet modulates microbial
physiology, products of microbial metabolism can enter the
host metabolome causing substantial variability in profiles.
Although urinary metabolite profiles have often been
used as a natural point to observe such interactions(37),
recent evidence suggests that there is a large contribution
of microbial by-products to the plasma metabolome(36).
A comparison of conventional (with microflora) and germ-
free (without microflora) mice has found numerous signals
exclusive to the presence of microflora, with approximately
a 10% difference in the metabolite profiles between
normal and germ-free animals(36). As well as products of
microbial metabolism of amino acids and other com-
pounds, the study has also found products of host phase II
metabolism raised in the presence of microflora, demon-
strating a direct effect on host drug metabolism capa-
city(36). Faeces are an obvious sample to study microflora
interactions, as profiles contain a plethora of compounds
related to microflora metabolism such as SCFA, organic
acids and amino acid derivatives(38). As the complement of
microflora differs between individuals there is considerable
inter- and intra-individual variation in profiles(38), but
interestingly this variation has been found to be a result of
differences in concentration rather than composition(38).
Nevertheless, as microflora seem to contribute to both
blood and urinary profiles they are an important contributor
to biological variation.
Data analysis
The data produced by metabolomics experiments are
highly complex; for example, >2000 features differing in
intensity by orders of magnitude are typically represented
in LC–MS analysis of plasma or urine. As the technology
aims to characterise changes to the metabolome in discreet
sets of samples powerful multivariate statistical analysis
techniques are required to process the data for sample
classification and clustering or discrimination. These tech-
niques essentially are data compression tools; by reducing
the dimensionality of the data it becomes easier to visua-
lise graphically so that patterns between groups of data
(samples) can be revealed. Both unsupervised and super-
vised techniques are commonly used. Principal component
analysis is an unsupervised method for sample classifica-
tion. The ‘principal components’ represent variance
between samples and so samples that are similar in their
metabolite profile will cluster together in a scores plot. An
important aspect of this method is that it does not require
information about sample classification and as such is a
good starting point to visualise the data. However, princi-
pal component analysis is often unable to classify similar
groups, which is typically found in nutritional studies, and
so other techniques are often used. Supervised methods,
such as partial least squares discriminant analysis, include
information on sample classification, making it more likely
that patterns of change between groups are visualised.
However, the downside is that it can lead to overanalysis,
e.g. partial least squares discriminant analysis will separate
groups from random data(39), and as such these methods
require appropriate model validation steps and adequate
training and predictive sample sets, usually with indepen-
dent data.
Clustering methods, as described earlier, only visualise
discriminated sample groups demonstrating whether the
metabolite profiles are different between sample groups.
This feature is important to establish, but of greater interest
is identifying what metabolites are responsible for the
variation between sample groups, as this information can
be used further downstream in pathway analysis and bio-
marker identification. Loadings plots are an extension to
score plots in which those features responsible for group
variation are visualised. Although this approach provides
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important information on the actual species (e.g. mass and
retention time in LC–MS experiments), further investiga-
tive work using metabolite databases (e.g. the human
metabolome database(40), METLIN(41)) and confirmatory
analysis using standards is required to be fully confident of
the assignment.
It should be noted that data analysis steps require careful
consideration and interpretation in order to be confident of
obtaining meaningful data.
Metabolomics in nutritional research
A number of studies applying metabolomics to nutri-
tional research have been performed (Table 1). A quick
comparison of these studies shows that various analytical
platforms and biological samples have been used. Gen-
erally, NMR has been the most common platform but
MS has been gaining popularity over recent years, per-
haps because of greater availability and improvement in
analytical technology and methodology. Urine is still the
commonest biological sample used, especially when NMR
is used as the platform, but a number of studies do
profile both urine and blood. It is interesting to note that
the first ‘real’ nutritional metabolomics study was per-
formed in 2003(42), which highlights the novelty of the
technology. These early studies have shown changes to
both the plasma(42) and later the urinary(43) metabolome
following ingestion of isoflavones (soyabean) in healthy
premenopausal women. In plasma there are changes to
lipoproteins, amino acids and carbohydrates following
intervention(42) while in urine there are changes associated
with modification of gut microflora(43). Importantly, the
‘urine’ study used controlled environmental conditions
with standardised meals, which perhaps contributed to
identifying subtle changes to the metabolome in a rela-
tively small subject population (five females). A number of
studies of differing design have been performed on tea
metabolism(44–46). While both black tea and chamomile tea
Table 1. A summary of human nutritional metabolomic studies
Reference Platform Study Sample
Solanky
et al.(42,43)
NMR Isoflavone (soyabean) intake in healthy females: daily controlled intake
either normal or rich in soya, 1 month per treatment (n 5; females)
Plasma(42), urine(43)
Lenz et al.(30) NMR Population comparisons, dietary influences: no intervention, compared healthy
British v. Swedish subjects (n 30; mixed)
Urine
Daykin
et al.(44)
NMR Black tea metabolism: single dose of black tea following a low-polyphenol diet
(n 3; mixed)
Urine
Wang et al.(46) NMR Chamomile-tea metabolism: 2 weeks control, then 2 weeks of tea every day,
then 2 weeks no tea; spot urines taken every day (n 14; mixed)
Urine
Van Dorsten
et al.(45)
NMR Comparison of green tea, black tea and caffeine: cross-over design; 2 d run-in
of low-polyphenol diet followed by 2 d treatment, 10 d washout (n 17; males)
Urine, plasma
Walsh et al.(34) NMR Dietary standardization: no intervention, three visits the latter two following
same dietary pattern (n 30; mixed)
Urine, plasma, saliva
Stella et al.(32) NMR Comparison of a vegetarian v. low-meat v. high-meat diets: randomised
cross-over design; 15 d treatment periods (n 12; men)
Urine
Walsh et al.(47) NMR and
LC–MS
Acute phytochemical intake: 6 d study, day 0 normal, days 1 and 2
low-phytochemical diet, days 3 and 4 addition of fruit and vegetables
(n 21; mixed)
Urine
Rezzi et al.(33) NMR Dietary preferences; chocolate intake: subjects defined by chocolate desiring
or not; 5 d study, days 2 and 4 subjects given chocolate or bread in
cross-over design with washout days between (eleven men in each group)
Plasma
Kemsley
et al.(77)
NMR Cu intervention: case study, three experimental phases with urine collections;
1st phase only collection, 2nd phase included dietary records, 3rd phase
collections followed 6 weeks of Cu supplement (n 6; men)
Urine
von Velzen
et al.(49)
NMR Wine polyphenols: double-blind controlled cross-over design, 2-week run-in
followed by 4 weeks of placebo and mix of wine and grape juice extract
(n 29; mixed)
Urine
Gru¨n et al.(48) GC–MS Microbial fermentation of polyphenol-rich extract and green tea: used samples
from study of von Velzen et al.(49); stool samples taken for 3 d following
eight cups green tea (n 26, mixed plasma and urine; n 1, faeces)
Plasma, urine, faeces
Jacobs
et al.(38)
NMR Microbial fermentation following grape juice, wine extract: double-blind
controlled cross-over design, 2-week run-in followed by 4 weeks of placebo,
grape juice extract and mix of wine and grape juice extract (n 53; mixed)
Faeces
Shaham
et al.(50)
LC–MS Targeted metabolite profiling following glucose challenge: analysis of a mixed
young (n 22; mixed) and older (n 25; mixed) population, both undergoing an
oral glucose tolerance test; targeted analysis of 191 metabolites
Plasma
Chorell
et al.(52)
GC–MS Exercise and influence of different CHO drinks: cross-over design, single
dose; 90min exercise followed by either water, low-CHO drink, high-CHO
drink or low-CHO and protein drink, 1-week washout (n 24; men)
Serum
Zhao et al.(51) LC–MS Changes to metabolome following oral glucose tolerance test: samples from
subjects undergoing an oral glucose tolerance test (n 16; not specified)
Plasma
LC, liquid chromatography; CHO, carbohydrate.
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confirm hippuric acid as a major species responsible for
variation(44,45), green tea produces additional effects on
metabolites involved in the citric acid cycle(46). The first
study to compare diets (vegetarian v. low meat v. high
meat) in a cross-over design (twelve men) has found cer-
tain metabolites characteristic of high meat (creatine, acyl
and free carnitine, trimethylamine N-oxide) and vegetarian
(p-hydroxyphenylacetate) diets(32). A comparison of nor-
mal, low-phytochemical and standardised-phytochemical
diets in twenty-one individuals (mixed gender) has found
increased hippuric acid excretion during the standard-
phytochemical diet and increased creatinine and methyl
histidine excretion during the low-phytochemical diet(47).
Interestingly, direct comparison of NMR and LC–MS
shows a similar classification of diets between the plat-
forms(47). An interesting study that has examined dietary
preferences has found a difference in the urinary and
plasma metabolite profile of subjects classified as either
‘chocolate desiring’ or ‘chocolate indifferent’ even before
any food intake, suggesting that dietary preference alone
influences metabolic rate and gut flora activity(33).
A number of studies have investigated microbial fermen-
tation of polyphenol-rich extracts such as grape juice or
wine extract and again have found the presence of hippuric
acid and its derivatives as well as phenolic acids as major
contributors to sample classification(38,48,49). Interestingly,
the use of faeces as a sample has demonstrated changes to
gut-flora fermentation induced by a wine extract(38). More
recently, metabolomic studies have investigated carbohy-
drate intake either during an oral glucose tolerance
test(50,51) or following consumption of energy drinks(52).
The former studies have identified various pathways sti-
mulated during the insulin response to glucose, some of
which have not previously been reported(50,51).
Metabolomics has been used to investigate the influence
of vitamin E supplementation (400 mg/d, 4 weeks) on
plasma metabolite profiles of twelve healthy men using
LC–MS (JK Lodge and MC Wong, unpublished results).
While principal component analysis has failed to demon-
strate discrimination of samples, a validated partial least
squares discriminant analysis model has been able to dis-
criminate samples pre- and post supplementation. Further
investigation of loadings plots has revealed several features
for further investigation that have been confirmed to be
significantly different pre- and post supplementation
(P<0.05). Preliminary identification of these features has
revealed a number of lysophospholipids that are sig-
nificantly increased following vitamin E supplementation
(P<0.05). Although the confirmation of these species is
still ongoing, this finding highlights the potential of the
technology in being able to identify changes to the meta-
bolome and the identification of novel areas of research
that may go unnoticed using conventional techniques.
Future perspectives for nutritional metabolomics
Although the potential of metabolomics is without
question, the technology is still faced with a number of
limitations and challenges. There is no single platform
that can analyse all metabolites in a biological sample and
so the limitations of each technology have to be taken into
account in experimental design. Obviously, a combination
of NMR, LC–MS and GC–MS would be ideal to provide
a more holistic measure of the metabolome, but this
approach itself brings important cost implications and an
increase in data analysis and complexity. There is currently
no standardisation in terms of the methodology associated
with sample collection, sample pretreatment and analytical
conditions. However, there have been recommendations
published to standardise metabolomic investigations and
their reporting(53,54), which will hopefully influence future
investigations. A major challenge is the influence of both
analytical and biological variability. Analytical variability
should improve with the advancement of technology and
standardisation of methodology, while the influence of
biological variability requires careful understanding of the
influence of a variety of factors such as gender, BMI, age,
recent dietary intake, gut microflora and general health, as
these factors have all been shown to influence the meta-
bolome. Furthermore, the influence of lifestyle, genetic and
environmental factors, which are important in the aetiology
of chronic disease, need to be further explored. Such con-
siderations have implications for study design to create a
relatively homogenous study population to reduce the
influence of biological variation.
Another major challenge faced is the identification of
metabolites. Although a number of databases are available
for most platforms (and should be used in conjunction with
each other), as the whole metabolome is not yet fully
characterised there will always be a problem with the
identification of ‘unknowns’. Although useful structural
information can be gained from further MS experiments
(e.g. fragmentation), identification ultimately requires the
use of standards, and if not commercially available the
assistance of synthetic chemists.
The future potential of this technology for nutritional
research can be envisaged at various levels. It will be
possible to integrate metabolomics with other ‘omic’
technologies to provide a more complete picture of the
metabolic phenotype. The identification of those metabo-
lites influenced by certain nutrients and/or dietary patterns
can be useful for predictive analysis with the possibility of
using fluxomics (dynamic changes of metabolites within a
cell over time) to investigate the flow of metabolites
through metabolic pathways, especially now, as human
metabolic networks have been constructed(55). A well-
established role for nutritional metabolomics has been
identified in the development of the nutritional phenotype
and for future personalised nutritional assessment(1,3,4,9). It
is thought that metabolomics can be used to predict the
response of the metabolome to nutrient or dietary inter-
vention and to predict dietary change required to modify
the metabolome to a ‘healthy’ phenotype. Although per-
sonalised nutrition is a long way off, metabolomics does
offer the possibility of characterising the complex interac-
tions between diet and the metabolome.
Targeted approaches
Targeted approaches are more hypothesis testing and
include those in which the nutrient(s) or metabolite(s) of
interest are known and information on concentration,
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bioavailability, turnover or metabolism are required. These
approaches can also be seen as a natural progression from
non-targeted approaches that are used in the first instance
to identify novel targets for such further studies. Targeted
analysis can cover either single nutrients or metabolites or
an analysis of metabolome subsets including lipids(56),
amino acids(57) and central metabolism(50). Indeed, the
profiling of lipids has developed into its own field of lipi-
domics and recent studies in this field, which include the
analysis of eicosanoid metabolism and signalling(58),
identifying lipids linked to inflammation following fish oil
intervention(59), phospholipid metabolism(60), monitoring
of lipid fluxes using stable isotopes(61) and evaluating dif-
ferential effects of statins(62), demonstrate how this parti-
cular field is rapidly progressing.
Simply measuring concentration alone provides only
limited information; therefore, in order to gain further
understanding of the physiology of a nutrient or metabolite
other approaches are required. A commonly-used method
is to employ a stable-isotope analogue of the target, which
as it should behave identically to the parent compound
allows the monitoring of that specific form in the body
following ingestion, providing information on absorption,
bioavailability, distribution, turnover, metabolism and
elimination(63,64). The use of stable isotopes in nutritional
research is extensive and a review of potential applications
is beyond the scope of the present report, but there are
several reviews that provide a starting point(64–67).
As an example of the benefits of using stable isotopes
this approach has been employed to monitor vitamin E
status in various populations using 2H-labelled a-
tocopheryl acetate(68). Vitamin E transport and delivery
within the body is governed by the kinetics of plasma
lipoprotein metabolism and much of what is now known
about vitamin E transport and distribution has been eluci-
dated using stable-isotope approaches. Intestinal absorption
requires the presence of adequate fat, and significant dif-
ferences have been demonstrated in the plasma uptake of
labelled a-tocopherol between meals containing 2.7 g fat
and 17.5 g fat (P<0.001)(69). It has been shown that during
the absorptive phase there is no discrimination between
vitamin E forms(70), but a number of biokinetic studies have
demonstrated the preferential secretion of a-tocopherol in
VLDL over other vitamin E forms(70), so that there is a
retention of a-tocopherol in the body(71). The monitoring
of labelled a-tocopherol in lipoproteins demonstrates that
a-tocopherol transport is dependent on lipoprotein kinet-
ics(72), with peaks in a-tocopherol concentration coincid-
ing with lipoprotein dynamics. Overall, following plasma
uptake of newly-absorbed a-tocopherol there is a simulta-
neous decrease in pre-existing or endogenous a-tocopherol
concentration. This rapid turnover of a-tocopherol in the
plasma such that the ‘new’ constantly replaces the ‘old’ is
an established phenomenon identified by stable-isotope
techniques(72,73) and also occurs within individual lipo-
proteins(72). A similar phenomenon has been found in
blood components, with different patterns of uptake in
erythrocytes, platelets and lymphocytes(72) representative
of simple diffusion or a more-regulated receptor-mediated
uptake. Following an understanding of nutrient physiology
in a healthy population a comparison can be made with
high-risk populations to provide clues as to how nutrient
physiology is influenced. Using stable isotopes differences
have been found in a-tocopherol biokinetics between
individuals who are normolipidaemic and hyperlipi-
daemic(74), between smokers and non-smokers(75) and
between individuals with the apoE3/3 and apoE3/4
alleles(76). Overall, these studies highlight that vitamin E
homeostasis is ultimately dependent on a combination of
factors that control its absorption, transport, distribution
and metabolism and that, translated to the field of nutri-
tional research, approaches using stable-isotopes are
essential to monitor nutrient status in vivo and their role in
the aetiology of disease.
Conclusions
With the combined array of targeted and non-targeted
approaches it is now possible to not only identify metabo-
lites and nutrients that are influenced by dietary change but
to also gain a greater understanding of nutrient and meta-
bolite physiology. Both approaches have proved successful
in a number of applications and used either alone or in
conjunction with one another they represent powerful
research methods with the potential of opening novel areas
of nutritional research and understanding the role of diet in
health and disease.
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